Treatment of osteoarticular, cardiovascular, intravascular-catheter-related and other complicated infections with dalbavancin and oritavancin: A systematic review

This publication has 54 references indexed in Scilit:

• Oritavancin Microbiologic Features and Activity Results From the Surveillance Program in the United States
  Clinical Infectious Diseases, 2012
• Risk Practices Associated with Bacterial Infections among Injection Drug Users in Denver, Colorado
  The American Journal of Drug and Alcohol Abuse, 2010
• Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates
  Antimicrobial Agents and Chemotherapy, 2009
• Oritavancin Kills Stationary-Phase and BiofilmStaphylococcus aureusCells In Vitro
  Antimicrobial Agents and Chemotherapy, 2009
• Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry
  International Journal Of Clinical Practice, 2008
• In Vivo Pharmacodynamic Activity of the Glycopeptide Dalbavancin
  Antimicrobial Agents and Chemotherapy, 2007
• Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens
  Diagnostic Microbiology and Infectious Disease, 2005
• Efficacy and Safety of Weekly Dalbavancin Therapy for Catheter-Related Bloodstream Infection Caused by Gram-Positive Pathogens
  Clinical Infectious Diseases, 2005
• Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital
  BMJ, 2004
• Financial Impact of a Home Intravenous Antibiotic Program on a Medicare Managed Care Program
  Clinical Infectious Diseases, 2000